The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 92, Issue 2, 2000, Pages 251-257

  Tjalma, Wiebren ^a,b   Weyler, Joost ^a   Weyn, Barbara ^b   Van Marck, Eric ^a,b   Van Daele, André ^b   Van Dam, Peter ^a,b   Goovaerts, Gerda ^b   Buytaert, Philippe ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; CD 31; Invasive cervical cancer; Prognosis; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

EID: 0033826166     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00295-X     Document Type: Article

References (40)

1. Folkman J., Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
2. Folkman J. What is evidence that tumours are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6.
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumour angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
4. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol. 184:1998;119-122.
5. Tjalma W., Van Marck E., Weyler J., et al. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer. 78:1998;170-174.
6. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
7. Fidler I.J., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
8. Neufeld G., Cohen T., Gitay-Goren H., et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 15:1996;153-158.
9. Plate K.H., Breier G., Welch H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845-848.
10. Obermair A., Wanner C., Bilgi S., et al. Tumour angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol. 178:1998;314-319.
11. Brown L.F., Berse B., Jackman R.W., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 26:1995;86-91.
12. Mattern J., Koomägi R., Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer. 73:1996;931-934.
13. Inoue K., Ozeki Y., Suganuma T., Sugiura Y., Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumour progression. Cancer. 79:1997;206-213.
14. Mise M., Arii S., Higashitudji H., et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumour. Hepatology. 23:1996;455-464.
15. Tokumo K., Kodama J., Seki N., et al. Different angiogenic pathways in human cervical cancers. Gynecol Oncol. 68:1998;38-44.
16. Hawighorst H., Knapstein P.G., Knopp M.V., et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumour angiogenesis and patient survival. Cancer Research. 58:1998;3598-3602.
17. Shepherd J.H. Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol. 103:1996;405-406.
18. Terris B., Scoazec J.Y., Rubbia L., et al. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology. 32:1998;133-138.
19. Harper M.E., Glynne-Jones E., Goddard L., Thurston V.J., Griffiths K. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. Br J Cancer. 74:1996;910-916.
20. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
21. Harris A.L. Antiangiogenesis for cancer therapy. Lancet. 349:(SII):1997;13-15.
22. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 108:1995;2369-2379.
23. Gordon J.D., Mesiano S., Zaloudek C.J., Jaffe R.B. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab. 81:1996;353-359.
24. Zhang L., Scott P.A., Turley H., et al. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol. 185:1998;402-408.
25. Brown L.F., Berse B., Tognazzi K., et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42:1992;1457-1461.
26. Abu-Jawdeh G.M., Faix J.D., Niloff J., et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest. 74:1996;1105-1115.
27. Pammer J., Weninger W., Mildner M., Burian M., Wojta J., Tschachler E. Vascular endothelial growth factor in constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol. 186:1998;186-191.
28. Weninger W., Uthman A., Pammer J., et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumours. Lab Invest. 75:1996;647-657.
29. Gasparini G., Toi M., Gion M., et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst. 89:1997;139-147.
30. Fontanini G., Vignati S., Boldrini L., et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res. 3:1997;861-865.
31. Crew J.P., O'Brein T., Bradburn M., et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res. 57:1997;5281-5285.
32. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumour vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol. 15:1997;826-832.
33. Ferrara N., Winer J., Burton T., et al. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest. 91:1993;160-170.
34. Claffey K.P., Brown L.F., del Aguila L.F., et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumour growth, angiogenesis, and experimental metastasis. Cancer Res. 56:1996;172-181.
35. Takahashi Y., Cleary K.R., Mai M., Kitadai Y., Bucana C.D., Ellis L.M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res. 2:1996;1679-1684.
36. Neeman M., Abramovitch R., Schiffenbauer Y.S., Tempel C. Regulation of angiogenesis by hypoxic stress: from solid tumours to ovarian follicle. Int J Exp Pathol. 78:1997;57-70.
37. Shweiki D., Neeman M., Itin A., Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multiple spheroids: implications for tumour angiogenesis. Proc Natl Acad Sci USA. 92:1995;768-772.
38. Stein I., Neeman M., Shweiki D., Itin A., Kesher E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol. 15:1995;5363-5368.
39. Dirix L.Y., Vermeulen P.B., Pawinski A., et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer. 76:1997;238-243.
40. Nelson N.J. Inhibitors of angiogenesis enter phase III testing. J Natl Cancer Inst. 90:1998;960-963.